These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25846334)

  • 1. Engineering the heterologous expression of lanthipeptides in Escherichia coli by multigene assembly.
    Kuthning A; Mösker E; Süssmuth RD
    Appl Microbiol Biotechnol; 2015 Aug; 99(15):6351-61. PubMed ID: 25846334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli.
    Caetano T; Krawczyk JM; Mösker E; Süssmuth RD; Mendo S
    Chem Biol; 2011 Jan; 18(1):90-100. PubMed ID: 21276942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioengineering of lanthipeptides in Escherichia coli: assessing the specificity of lichenicidin and haloduracin biosynthetic machinery.
    Caetano T; Barbosa J; Möesker E; Süssmuth RD; Mendo S
    Res Microbiol; 2014 Sep; 165(7):600-4. PubMed ID: 25058408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lichenicidin rational site-directed mutagenesis library: A tool to generate bioengineered lantibiotics.
    Barbosa J; Caetano T; Mösker E; Süssmuth R; Mendo S
    Biotechnol Bioeng; 2019 Nov; 116(11):3053-3062. PubMed ID: 31350903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
    Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
    J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lichenicidin biosynthesis in Escherichia coli: licFGEHI immunity genes are not essential for lantibiotic production or self-protection.
    Caetano T; Krawczyk JM; Mösker E; Süssmuth RD; Mendo S
    Appl Environ Microbiol; 2011 Jul; 77(14):5023-6. PubMed ID: 21602391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congeneric lantibiotics from ribosomal in vivo peptide synthesis with noncanonical amino acids.
    Oldach F; Al Toma R; Kuthning A; Caetano T; Mendo S; Budisa N; Süssmuth RD
    Angew Chem Int Ed Engl; 2012 Jan; 51(2):415-8. PubMed ID: 22128014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of phloroglucinol by Escherichia coli using a stationary-phase promoter.
    Cao Y; Xian M
    Biotechnol Lett; 2011 Sep; 33(9):1853-8. PubMed ID: 21544607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems metabolic engineering of Escherichia coli for gram scale production of the antitumor drug deoxyviolacein from glycerol.
    Rodrigues AL; Becker J; de Souza Lima AO; Porto LM; Wittmann C
    Biotechnol Bioeng; 2014 Nov; 111(11):2280-9. PubMed ID: 24889673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Screening of Lanthipeptide Analogs via In-Colony Removal of Leader Peptides in Escherichia coli.
    Si T; Tian Q; Min Y; Zhang L; Sweedler JV; van der Donk WA; Zhao H
    J Am Chem Soc; 2018 Sep; 140(38):11884-11888. PubMed ID: 30183279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterologous Expression of Mersacidin in
    Viel JH; Jaarsma AH; Kuipers OP
    ACS Synth Biol; 2021 Mar; 10(3):600-608. PubMed ID: 33689311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Expression of GFP-Fused Class I Lanthipeptides in
    Van Staden ADP; Faure LM; Vermeulen RR; Dicks LMT; Smith C
    ACS Synth Biol; 2019 Oct; 8(10):2220-2227. PubMed ID: 31553571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the mCherry fluorescent protein to optimize the expression of class I lanthipeptides in Escherichia coli.
    Van Zyl WF; Van Staden AD; Dicks LMT; Trindade M
    Microb Cell Fact; 2023 Aug; 22(1):149. PubMed ID: 37559122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of domestication in the production of the class II lanthipeptide lichenicidin by Bacillus licheniformis I89.
    Caetano T; Süssmuth RD; Mendo S
    Curr Microbiol; 2015 Mar; 70(3):364-8. PubMed ID: 25399299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, dynamics and kinetics of two-component Lantibiotic Lichenicidin.
    de Miguel A; Tapia-Rojo R; Utesch T; Mroginski MA
    PLoS One; 2017; 12(6):e0179962. PubMed ID: 28654661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ePathBrick: a synthetic biology platform for engineering metabolic pathways in E. coli.
    Xu P; Vansiri A; Bhan N; Koffas MA
    ACS Synth Biol; 2012 Jul; 1(7):256-66. PubMed ID: 23651248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic Construction and Screening of Lanthipeptide Variant Libraries in
    Guo E; Fu L; Fang X; Xie W; Li K; Zhang Z; Hong Z; Si T
    ACS Synth Biol; 2022 Dec; 11(12):3900-3911. PubMed ID: 36379012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro reconstitution of mevalonate pathway and targeted engineering of farnesene overproduction in Escherichia coli.
    Zhu F; Zhong X; Hu M; Lu L; Deng Z; Liu T
    Biotechnol Bioeng; 2014 Jul; 111(7):1396-405. PubMed ID: 24473754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of cytidine production by coexpression of gnd, zwf, and prs genes in recombinant Escherichia coli CYT15.
    Fang H; Xie X; Xu Q; Zhang C; Chen N
    Biotechnol Lett; 2013 Feb; 35(2):245-51. PubMed ID: 23070626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class II two-peptide lanthipeptide proteases: exploring LicTP for biotechnological applications.
    Barbosa JC; Mösker E; Faria R; Süssmuth RD; Mendo S; Caetano T
    Appl Microbiol Biotechnol; 2023 Mar; 107(5-6):1687-1696. PubMed ID: 36763118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.